ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1837–1848 of 2020 project topics
Periodic Fever Aphthous Ulcers TNFRSF1A Testing Service
A direct-to-consumer genetic testing service that screens for TNFRSF1A pathogenic variants with comprehensive clinical interpretation and symptom tracking integration. This generates high-margin test fees while building a proprietary patient registry valuable for biotech partnerships and drug development outcomes research.
Genetic Basis of Autoinflammatory Skin Diseases Click to view more details →
Chronic Infantile Neurological Cutaneous NLRP3 Analysis Suite
An integrated bioinformatics software suite that identifies and characterizes NLRP3 gain-of-function mutations with real-time phenotype correlation dashboards. The platform serves pediatric hospitals and specialty clinics through annual subscriptions while enabling real-world evidence collection for IL-1 inhibitor manufacturers.
Genetic Basis of Autoinflammatory Skin Diseases Click to view more details →
Systemic Autoinflammatory Disease IL1B Profiling Commercial Kit
A branded next-generation sequencing kit and analysis workflow that profiles IL1B regulatory mutations and predicts treatment responsiveness to biologic therapies. This consumable product generates recurring revenue through kit sales to clinical laboratories while establishing market dominance in autoinflammatory genetic testing.
Genetic Basis of Autoinflammatory Skin Diseases Click to view more details →
Autoinflammatory Syndrome Genotype-Phenotype Prediction Engine
A machine learning platform trained on multi-gene autoinflammatory variants that predicts disease progression, organ involvement, and therapeutic response before clinical manifestation. The platform licenses to biopharma companies for patient enrichment in clinical trials and generates ongoing data monetization revenue from aggregated outcome tracking.
Genetic Basis of Autoinflammatory Skin Diseases Click to view more details →
SCN4A Periodic Paralysis and Myotonia Testing
Characterizing SCN4A gain and loss-of-function variants causing paramyotonia, hyperkalemic periodic paralysis, and sodium channel myotonias.
Genetic Basis of Skeletal Muscle Channelopathies Click to view more details →
CACNA1S Hypokalemic Periodic Paralysis Type 1
Identifying CACNA1S variants at arginine residues in voltage sensor domains causing HypoPP1 for molecular diagnosis and acetazolamide therapy guidance.
Genetic Basis of Skeletal Muscle Channelopathies Click to view more details →
KCNJ2 Andersen-Tawil Syndrome Testing
Characterizing KCNJ2 loss-of-function variants causing ATS for molecular diagnosis in patients with triad of periodic paralysis, arrhythmias, and dysmorphic features.
Genetic Basis of Skeletal Muscle Channelopathies Click to view more details →
Myotonia Congenita CLCN1 Gene Analysis
Developing comprehensive CLCN1 testing for Thomsen and Becker myotonia for molecular diagnosis and correlating with mexiletine treatment response.
Genetic Basis of Skeletal Muscle Channelopathies Click to view more details →
KCNQ2/KCNQ3 Neonatal Epilepsy SaaS Diagnostic Platform
A cloud-based diagnostic platform that sequences and analyzes KCNQ2/KCNQ3 variants in neonates with benign familial neonatal-infantile seizures, enabling rapid genetic confirmation and treatment stratification. This platform reduces time-to-diagnosis by 60% and captures recurring testing revenue through subscription-based variant curation and clinical interpretation services.
Genetic Basis of Skeletal Muscle Channelopathies Click to view more details →
RYR1 Malignant Hyperthermia Pharmacogenomics Testing Service
An industry-grade testing service that identifies RYR1 and CACNA1S pathogenic variants in pre-surgical patients to prevent anesthetic-triggered malignant hyperthermia complications. The service monetizes through high-volume hospital partnerships, insurance reimbursement, and integration with perioperative decision-support systems.
Genetic Basis of Skeletal Muscle Channelopathies Click to view more details →
TRPM4 Familial Cardiac Conduction Disease Predictive Tool
A machine-learning predictive tool that stratifies cardiovascular risk in TRPM4 mutation carriers by integrating genetic data with clinical phenotyping and electrophysiological biomarkers. The tool generates recurring licensing revenue from cardiology centers and payers through risk-based intervention algorithms and outcome tracking.
Genetic Basis of Skeletal Muscle Channelopathies Click to view more details →
SCN5A Brugada and Long QT Syndrome Variant Database Platform
A proprietary variant interpretation database and clinical decision-support platform that catalogs SCN5A mutations associated with Brugada syndrome and Long QT Syndrome Type 3 with actionable clinical evidence. This B2B SaaS generates recurring revenue through laboratory licensing, continuous variant reclassification services, and integration with EHR systems.
Genetic Basis of Skeletal Muscle Channelopathies Click to view more details →